https://www.selleckchem.com/pr....oducts/4-hydroxytamo
A 4-week treatment with ADs caused the improvement of psychopathology symptoms estimated by Positive and Negative Syndrome Scale (PANSS) that was accompanied by decreased lipid peroxidation (F2-isoprostanes, TBARS; p=2.9x10 , p=7.6x10 , respectively) and an increase in total antioxidative capacity (FRAP) (p=5.16x10 ). Atypical antipsychotics especially clozapine, olanzapine and quetiapine demonstrate the effective outcome of antipsychotic treatment, beneficial antioxidative action by reducing lipid peroxidati
Me gusta
Comentario
Compartir
